Back to portfolio

Variant Bio, Inc.

Developing therapies based on genetic information of people who are outliers for medically relevant traits

Variant Bio was founded in 2018 by Kaja Wasik and Stephane Castel and Sponsored by Lux Capital. The company, under the direction of CEO Andrew Farnum is developing therapies that will improve global health by studying the genes of people with exceptional health-related traits.